Plain-English translation of NCT03174938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The Swedish BioFINDER 2 Study is testing new ways to diagnose memory and thinking disorders early — before major symptoms appear — by looking for specific markers in blood, spinal fluid, and brain imaging. Researchers want to develop simple, affordable blood tests and advanced imaging techniques that can identify people at risk of diseases like Alzheimer's and Parkinson's disease, so they can be helped sooner.
Memory and thinking disorders are often misdiagnosed, and by the time symptoms appear, significant brain damage has already happened. This study aims to catch these diseases much earlier — when the brain may still be able to recover — so that new treatments can work better and people get the right diagnosis the first time.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you will visit the clinic every 2 years for 8 years for memory and thinking tests, blood draws, and spinal fluid collection. You will also have brain imaging scans (MRI and PET) every 4 years, or more frequently if initial scans show signs of disease. Each visit takes several hours, and the study aims to follow your brain health over time to see how these new testing methods work.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Sweden